| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/27/2006 | US20060167228 Sequences from an endosymbiont and their uses |
| 07/27/2006 | US20060167226 Mutations of voltage-gated ion channnels that allow them to express a voltage-independent phenotype and an improved method to use the same |
| 07/27/2006 | US20060167225 Novel fluorescent protein from aequorea coerulscens and methods for using the same |
| 07/27/2006 | US20060167221 Process for the extraction and isolation of insulin from recombinant sources |
| 07/27/2006 | US20060166915 Human coagulation factor VII polypeptides |
| 07/27/2006 | US20060166912 Use of cytochrome p450 enzyme cyp2w1 as a drug target for cancer theraphy |
| 07/27/2006 | US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes |
| 07/27/2006 | US20060166888 for arachidonic acid release in target cells; intracellular calcium release; phospholipases |
| 07/27/2006 | US20060166875 Single chain recombinant t cell receptors |
| 07/27/2006 | US20060166874 Fvii or fviia variants having increased clotting activity |
| 07/27/2006 | US20060166329 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin |
| 07/27/2006 | US20060166328 IGF-I fusion polypeptides and therapeutic uses thereof |
| 07/27/2006 | US20060166327 G-protein chemokine receptor; use in drug screening and diagnosis of conditions related to the underexpression of the G-protein coupled receptor polypeptides by detecting a mutation |
| 07/27/2006 | US20060166326 Fusion proteins; host cells |
| 07/27/2006 | US20060166325 Glial cell line-derived neurotrophic factor receptor |
| 07/27/2006 | US20060166324 Screening tools for discovery of novel anabolic agents |
| 07/27/2006 | US20060166323 Providing or maintaining the cell under non-inducing conditions, where the cell comprises at least one of the recombinant nucleic acid (promoters); controlling the transcription of nucleic acid |
| 07/27/2006 | US20060166322 Cellulases; beta-glucosidases; hydrolases; conversion of cellulose to sugars and/or ethanol; laundry detergents |
| 07/27/2006 | US20060166321 Recombinant influenza vectors with tandem transcription units |
| 07/27/2006 | US20060166320 In vitro expression of the HCV ARFP/F-core‘coding open reading frame |
| 07/27/2006 | US20060166319 Charging tRNA with pyrrolysine |
| 07/27/2006 | US20060166318 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles |
| 07/27/2006 | US20060166317 Nucleic acids encoding sialytransferases from C. jejuni |
| 07/27/2006 | US20060166316 Phosphodiesterase 10a7 isoforms and methods of use |
| 07/27/2006 | US20060166315 Process for producing pnpase |
| 07/27/2006 | US20060166314 Method for rational mutagenesis of alpha/beta t-cell receptors and correspondingly mutated mdm2-protein specific alpha/beta t-cell ceceptores |
| 07/27/2006 | US20060166313 Novel glycero kinase, gene thereof and process for producing the glycerol kinase by using the gene |
| 07/27/2006 | US20060166312 Novel microorgnaism sensitive to lysozyme |
| 07/27/2006 | US20060166311 Novel notch-origin polypeptides and biomarkers and reagents using the same |
| 07/27/2006 | US20060166310 Serotonin receptor |
| 07/27/2006 | US20060166309 Novel G-protein coupled receptors |
| 07/27/2006 | US20060166306 Methods and compositions for in vitro synthesis of biological macromolecules in a cell-free system enriched with atp-sulfurylase |
| 07/27/2006 | US20060166304 Polynucleotides encoding insect 3-ketosphinganine reductase and uses thereof |
| 07/27/2006 | US20060166294 Apoptosis marker antibodies and methods of use |
| 07/27/2006 | US20060166275 Amyloid beta protein (globular assembly and uses thereof) |
| 07/27/2006 | US20060166274 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2006 | US20060166267 Facilitates the isolation of proteins from the cell nucleus interior as an independent fraction by separating the complete proteome into partial proteomes and thus makes this fraction available for further analyses for the first time in adequate purity and quality |
| 07/27/2006 | US20060166265 Survivin-binding proteins, encoding nucleic acids, and methods of use |
| 07/27/2006 | US20060166256 IL-1 receptor accessory protein |
| 07/27/2006 | US20060166225 Methods and compositions for polypeptide engineering |
| 07/27/2006 | US20060166220 having apoptotic activity; exhibited anti-proliferative activity when expressed in transformed cells |
| 07/27/2006 | US20060166214 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 07/27/2006 | US20060166213 Novel compositions and methods in cancer |
| 07/27/2006 | US20060166211 Ss 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same |
| 07/27/2006 | US20060166202 proteins comprising an amino acid sequence including the catalytic region and regulatory domains; the protein inhibits neurite retraction in an (lysophosphatidic acid) LPA-induced neurite retraction bioassay; used for treating nervous system disorders and/or injuries |
| 07/27/2006 | US20060166198 Providing a first population of single-stranded polynucleotide molecules and a second population of single-stranded polynucleotide molecules, carrying out reaction for digesting, contacting polynucleotide fragments generated from plus strands with fragments generated from the minus strands, amplifying |
| 07/27/2006 | US20060166193 Binding protein |
| 07/27/2006 | US20060166186 Detecting a compartment or a macromolecule of a cell by expressing a polynucleotide encoding chimeric polypeptide in the cell having single chain Fv region that binds a detectable molecule and a S-AKAP84 region that binds the macromolecule or targets the compartment; exposing cell to molecule; analyzing |
| 07/27/2006 | US20060165729 Protein from photobacterium damselae and use thereof |
| 07/27/2006 | US20060165727 Vaccine; inducing an immune response; infectious diseases, which can be caused by more than one strain, clade, variant, subtype or serotype of infectious disease causing microorganism; reliable vaccination against all Dengue virus serotypes |
| 07/27/2006 | US20060165725 HBV drug resistance drug resistance detection methods |
| 07/27/2006 | US20060165723 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle |
| 07/27/2006 | US20060165719 Plasmodium falciparum antigens and methods of use |
| 07/27/2006 | US20060165713 Vaccine |
| 07/27/2006 | US20060165712 can catalyze site-selective acyl transfer |
| 07/27/2006 | US20060165709 stimulate T cytotoxic lymphocytes in a mammal |
| 07/27/2006 | US20060165707 Substances |
| 07/27/2006 | US20060165706 Antibodies against CTLA4 and uses therefor |
| 07/27/2006 | US20060165698 Polypeptide from ink of molluscs; L-lysine or L-arginine oxidase capable of producing hydrogen peroxide in tumor tissues with less toxic side effects upon normal cells |
| 07/27/2006 | US20060165695 Antibody against human insulin-like growth factor |
| 07/27/2006 | US20060165694 Fab fragments and their DNA sequences used for preparation of complete recombinant Anti-Rhesus D antibodies; biodrugs; medical diagnosis |
| 07/27/2006 | US20060165693 treating a patient having cancer |
| 07/27/2006 | US20060165692 Humanized anti-CD3 specific antibodies |
| 07/27/2006 | US20060165691 Humanized anti-CD3 specific antibodies |
| 07/27/2006 | US20060165689 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 07/27/2006 | US20060165684 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions; inhibiting proliferation of peripheral blood mononuclear cells |
| 07/27/2006 | US20060165678 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 07/27/2006 | US20060165673 proteins having transferase activity comprising amino acid sequences modified to be in detectably labeled form, used for therapy and drug screening |
| 07/27/2006 | US20060165668 Genetically modified tumor cells as cancer vaccines |
| 07/27/2006 | US20060165661 Pediocin-producing pediococci |
| 07/27/2006 | US20060165654 Peptides and recombinant proteins mimicking interferons |
| 07/27/2006 | US20060165651 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/27/2006 | US20060165613 High performance in detergent compositions; superior cleaning and stain removal; cleaning a fabric, a dishware or hard surface |
| 07/27/2006 | US20060165592 Nk cell receptor conjugates for treating malignancies |
| 07/27/2006 | DE19929485B4 Lytisches Enzym Lytic enzyme |
| 07/27/2006 | DE102005002353A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications |
| 07/27/2006 | DE10101962B4 DNA-Sequenz mit regulatorischen Bereichen zur Expression von Proteinen DNA sequence with regulatory regions for expression of proteins |
| 07/26/2006 | EP1683811A2 Compositions and methods for the treatment of tumors |
| 07/26/2006 | EP1682664A2 Methods for the production of apolipoproteins in transgenic plants |
| 07/26/2006 | EP1682569A2 Cellular membrane protein assay |
| 07/26/2006 | EP1682106A2 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 07/26/2006 | EP1573314A4 Transgenic mice expressing human cd20 |
| 07/26/2006 | EP1438411B1 Use of aminoglycoside resistance gene |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1351974B1 Using viruses to detect or purify proteins |
| 07/26/2006 | EP1263784B1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 07/26/2006 | EP1161522B1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
| 07/26/2006 | EP1125130B1 Detection of acid-resistant micro-organisms in a stool |
| 07/26/2006 | EP1068301B1 Bacterial transglutaminases |
| 07/26/2006 | EP0934424B1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 07/26/2006 | EP0758396B1 Feline immunodeficiency virus vaccine |
| 07/26/2006 | CN1809643A Insertion of furin protease cleavage sites in membrane proteins and uses thereof |
| 07/26/2006 | CN1809641A Protein production system |
| 07/26/2006 | CN1809277A Tolerance to graft prior to thymic regeneration |
| 07/26/2006 | CN1807653A Active donkey-hide gelatin collagen peptide product |
| 07/26/2006 | CN1807596A Preparation method of polyclonal antibody of cellular karyoplasms transferring acceptor protein 13 |
| 07/26/2006 | CN1807586A Method for inducing rice blast bacteria to produce pathogeneic protein |
| 07/26/2006 | CN1807573A Coriolus versicolor strain and method for producing Coriolus versicolor intracellular glycopeptide using the strain |
| 07/26/2006 | CN1807455A Breast cancer related gene DREE, its coded protein and uses |
| 07/26/2006 | CN1807449A BIM apoptosis effect minimum core sequence and its preparation and uses |